SUMMARY
The combination of sufentanil with bupivacaine plus adrenaline given extradura/ly for pain relief during labour was studied in a double-blind trial. One hundred and twenty patients were randomly divided into three groups and received a 10-ml extradural injection of sufentanil 15 ng +bu-pivacaine 12.5 mg + adrenaline 12.5 fig, sufentanil 7.5 fig + bupivacaine 12.5 mg +adrenaline 12.5 fig, or bupivacaine 12.5 
mg +adrenaline 12.5 ftg (control group). A second injection, which was given upon request, was identical to the first. Subsequently, patients received a further 10 ml of bupivacaine + adrenaline, if required.
The addition of sufentanil significantly decreased the latency, and increased the duration, of the analgesia. Moreover, the quality of analgesia was better and less bupivacaine was required, resulting in less motor blockade at delivery. There were no differences between the three groups in regard to Apgar scores. The only side effect of sufentanil was pruritis.
The aim of this study was to evaluate, in a double-blind manner, whether the combined use of sufentanil 15 ug or 7.5 ug with 0.125% bupivacaine plus adrenaline by the extradural route: (1) improved analgesia during labour and delivery; (2) reduced the total dose of bupivacaine and the degree of motor blockade; (3) had any unwanted effects on mother or baby.
PATIENTS AND METHODS
The design of the study was approved by the Hospital Ethics Committee. One hundred and twenty women who desired extradural analgesia for delivery were randomly divided into three equal groups. An extradural catheter was inserted at either the L2-3 or L3-^ lumbar intervertebral space. They received an initial injection of 10 ml containing one of the following drug combinations:
group A: sufentanil 15 ug + bupivacaine 12.5 mg + adrenaline 12.5 ug; group B: sufentanil 7.5 ug + bupivacaine 12.5 mg + adrenaline 12.5 ug; group C: bupivacaine 12.5 mg + adrenaline 12.5 ug. A second injection, which was given on the request for further analgesia, was identical to the first. Subsequently, but only if necessary, patients received a further 10 ml of bupivacaine 12.5 mg + adrenaline 12.5 ug. All the drugs were supplied in coded ampoules by Janssen Pharmaceuticals.
For the entire duration of labour, the parturient lay on her side, except during obstetric examination and extradural injection-which were performed in the supine position, with the uterus pushed manually to the left, or with the back slightly raised. If analgesia of the perineum was required an injection was made in the sitting position.
The times of injection and of the onset of analgesia were recorded. The patient's evaluation of the efficacy of the analgesia was assessed using the method of Bleyaert and colleagues (1979) which has a four-point scale of excellent, good, moderate and inefficient. At birth, motor block in the mother's abdominal muscles was assessed using a scale of total, marked, partial or no paralysis, according to the method of Van Zundert and colleagues (1984) . The Apgar scores of the infants at 1 and 5 min were noted, as was the mode of delivery. The mothers were seen on the day after delivery for a general evaluation of the pain relief they had experienced which was graded as perfect, very good, good or insufficient, according to the stage of labour.
Because extradural analgesia makes the timing of the classical stages of labour difficult, we divided labour into a dilatation phase and an expulsion phase. The pain experienced during episiotomy was assessed in a similar manner.
All side effects were recorded and these included nausea, vomiting, pruritis, dizziness, headache and urinary retention.
Statistical analysis
Intergroup comparisons of continuous variables were made using Student's t test for independent samples: the Mann-Whitney test was used for scored variables, and the x* test for nominal variables.
RESULTS
Of the 120 women taking part in the study, 13 were excluded for the following reasons: six underwent Caesarean section, the catheter was displaced in one, 1 coded ampoule was broken, three deliveries occurred soon after the first injection, and two inductions of labour were discontinued before labour was fully established.
The remaining 107 parturients formed three homogeneous groups of 37 (group A), 36 (group The results concerning analgesia are given in tables II, III and IV. Sufentanil significantly reduced the onset time, although the difference was only about 2 min. However, the duration of analgesia produced by the first injection was 45 min longer (130 min) in the sufentanil groups compared with the control group (85 min). As a result the hourly dose of bupivacaine was smaller in the groups which received sufentanil. The statistical analysis of the quality of the analgesia showed significantly better results in the two groups which received sufentanil, on both the first and second injections.
General evaluation of the analgesia over the whole of labour is given in table V. Twenty-five of 36 women in group A, and 28 of 35 in group B, judged the analgesia to be "perfect" for the dilatation stage of labour against 18 of 34 in the control group. For the expulsion stage the difference in evaluation was not significantly in favour of the groups that received sufentanil. The same results emerged in connection with episiotomy.
The use of sufentanil did not modify the duration of expulsion, nor the use of instrumental extraction (vacuum extractor only), the latter depending largely on the obstetrician's judgement. Apgar scores at 1 min were significantly lower in group A, but at 5 min they were equal in the three groups (table IV) .
Motor blockade in the mother at delivery was significantly less marked in the two groups that received sufentanil (table VI), although no mother had total paralysis. Amongst the other unwanted effects, only pruritis could be attributed to sufentanil (table VII) . It was not troublesome, remained mostly confined to the abdomen, and lasted 10-20 min. Sufentanil 15 ug had a higher incidence (43%) than 7.5 ug (22%). There was also an indication that dizziness was commoner with the higher dose.
DISCUSSION
These results agree with those of previous studies in which bupivacaine and fentanyl were combined (Justins et al., 1982; Van Steenberge, 1983) . Overall satisfaction was unquestionably superior, the onset of adequate analgesia was quicker, and the duration of the analgesia produced by the first injection was increased. Consequently, the hourly bupivacaine requirement was significantly reduced, and "top-up" injections were required less frequently (90-150 min compared with 45-90 min). The less satisfactory results in the control group can be explained by the fact that, in most of the patients who rated analgesia as "good" rather than "excellent", a painful spot persisted on one side-presumably the result of a "missed segment". In addition, rapid dilatation and excessive contractions were not sufficiently relieved by a first injection of bupivacaine 12.5 mg and adrenaline.
The association of a small dose of sufentanil with a low dose of bupivacaine plus adrenaline, administered extradurally, offers a definite advantage in obstretric analgesia. It produces analgesia of long duration which rapidly attains excellence. This decreases the total dose of bupivacaine required, with a minimal degree of motor block at delivery and well maintained Apgar scores in the infant.
The unwanted effects of sufentanil are of no consequence and toxicity is negligible at the doses used. Thus the addition of an opioid allows relief of any residual pain resulting from an incomplete sensory block. While extradural opioid by itself is insufficient to relieve the pain of labour completely, it is quite effective in making up for any deficiency in the efficacy of the extradural blockade produced by local anaesthetics.
This additive effect of using two drugs, each with totally different sites and modes of action, has several potential clinical advantages. In particular, it will increase the effectiveness of the analgesia without increasing the risk of overdosage. In this way a low dose of each component of the mixture can be used.
While most centres in the United Kingdom use 0.25-0.5 % bupivacaine for relief of pain in labour, we have for many years obtained reasonable results with 0.125%. This concentration rarely causes marked motor blockade and the risk of toxicity to either the mother or the baby is very low. However, the present study has shown that, in some mothers at least, the analgesia leaves something to be desired. By adding sufentanil the chance of failing to achieve good analgesia is greatly decreased. Our results would indicate that 7.5-15 ug of sufentanil per injection is quite sufficient in most patients; the normal i.v. analgesic dose is 30 ug.
The 40 % prolongation of analgesia achieved in this study when sufentanil was added to bupivacaine has practical advantages because "topup" injections are required less frequently and the dose of bupivacaine is reduced. This means that motor blockade is even less obvious than when 0.125% bupivacaine is used alone.
